Literature DB >> 24974492

Clostridium difficile infection at a tertiary care hospital in south India.

Shashidhar Vishwanath, Arpita Singhal, Annet D'Souza, Chiranjay Mukhopadhyay, Muralidhar Varma, Indira Bairy.   

Abstract

OBJECTIVE: The objective of this study was to detect C. difficile in patients presenting with Antibiotic Associated Diarrhoea.
METHODS: Stool samples from twenty-five patients collected over a period of four months were processed for C. difficile by culture and the isolates were identified following standard methods. C. difficile toxins A and B and C. perfringens enterotoxin were detected by ELISA performed directly on stool specimens.
RESULTS: Four patients (16%) were found positive for C. difficile infection. All patients with C. difficile infection received prior treatment with third-generation cephalosporins or beta-lactam/beta-lactamase inhibitor antibiotics. C. perfringens enterotoxin was found in two (8%) patients. Severe colitis was seen in one (25%) of the four patients who had co-infection with C. difficile and C. perfringens.
CONCLUSION: This study demonstrated a significant occurrence of C. difficile infection in this hospital population. There is a need to further evaluate the role of C. perfringens in causing antibiotic associated diarrhoea. Good clinical and laboratory studies to generate local epidemiological data are essential to increase awareness among the treating clinicians about C. difficile infection. Also limited and rational use of broad spectrum antibiotics is recommended.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24974492

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  8 in total

1.  Molecular epidemiology of toxigenic Clostridioides difficile isolates from hospitalized patients and the hospital environment in Dhaka, Bangladesh.

Authors:  Amelia K Sofjan; Mohammad Aminul Islam; Kakali Halder; Nayel D Kabir; Ahmed Abu Saleh; Julie Miranda; Chris Lancaster; Khurshida Begum; M Jahangir Alam; Kevin W Garey
Journal:  Anaerobe       Date:  2019-07-26       Impact factor: 3.331

2.  Anaerobic Bacteria in Clinical Specimens - Frequent, But a Neglected Lot: A Five Year Experience at a Tertiary Care Hospital.

Authors:  Padmaja Ananth Shenoy; Shashidhar Vishwanath; Ashwini Gawda; Seema Shetty; Renuka Anegundi; Muralidhar Varma; Chiranjay Mukhopadhyay; Kiran Chawla
Journal:  J Clin Diagn Res       Date:  2017-07-01

Review 3.  The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact.

Authors:  Nienke Z Borren; Shadi Ghadermarzi; Susan Hutfless; Ashwin N Ananthakrishnan
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

4.  Toxigenic Clostridium difficile isolates from clinically significant diarrhoea in patients from a tertiary care centre.

Authors:  Meenakshi Singh; Chetana Vaishnavi; Rakesh Kochhar; Safrun Mahmood
Journal:  Indian J Med Res       Date:  2017-06       Impact factor: 2.375

5.  Epidemiology of Clostridium difficile infection in hospitalized adults and the first isolation of C. difficile PCR ribotype 027 in central China.

Authors:  Yu Zhou; Liyan Mao; Jing Yu; Qun Lin; Ying Luo; Xuhui Zhu; Ziyong Sun
Journal:  BMC Infect Dis       Date:  2019-03-07       Impact factor: 3.090

Review 6.  Systematic Literature Review on Burden of Clostridioides difficile Infection in India.

Authors:  Canna J Ghia; Shaumil Waghela; Gautam S Rambhad
Journal:  Clin Pathol       Date:  2021-05-31

7.  Clostridioides difficile Diarrhea: An Emerging Problem in a South Indian Tertiary Care Hospital.

Authors:  Rachana Kannambath; Rakhi Biswas; Jharna Mandal; Kolar V Vinod; Biswajit Dubashi; Narayanan Parameswaran
Journal:  J Lab Physicians       Date:  2021-07-09

8.  Use of culture- and ELISA-based toxin assay for detecting Clostridium Difficile, a neglected pathogen: A single-center study from a tertiary care setting.

Authors:  Sujata Lall; Gita Nataraj; Preeti Mehta
Journal:  J Lab Physicians       Date:  2017 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.